The forecast for hospital discharges for carcinoma in situ in France shows a gradual decline from 16.2 in 2024 to 13.9 in 2028 per hundred thousand persons. In 2023, it was approximately 16.8. The year-on-year variations indicate a steady decrease of around 3.7% per annum. Over the five-year period, the compound annual growth rate (CAGR) reveals an average yearly decline of 4.96%. This consistent downward trend suggests improved early detection and treatment practices or changes in healthcare policies affecting hospital discharges.
Future trends to watch include advancements in medical technology that could further reduce discharge rates. Additionally, shifts in healthcare policy or public awareness of early cancer detection might impact these numbers. Monitoring these factors will be essential for anticipating changes in hospitalization rates for carcinoma in situ.
